Korsana Biosciences
KRSA
37.56
+2.11
+5.95%
Korsana Biosciences
US · KRSA
#2830 by market cap
Listed 1970
37.56
+2.11
+5.95%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Korsana Biosciences
Korsana Biosciences, Inc. is a biopharmaceutical company, which engages in discovering and developing novel therapies to reduce the burden of neurodegenerative diseases. Its portfolio includes the KRSA-028 pipeline. The company was founded in 2024 and is headquartered in Waltham, MA.
- Founded
- 2024
- CEO
- Dr. Jonathan Violin, M.B.A.,PhD
- Employees
- 19
- Headquarters
- Waltham, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- korsana.com
Company profile
- Exchange
- US
- Symbol
- KRSA
- Market-cap rank
- #2830
- Listing date
- 1970-01-01
- Market cap
- 1.71B
- Float cap
- 1.23B
- Shares out
- 45.54M
- Float shares
- 32.75M
Sectors & themes
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Korsana Biosciences discussion 0 comments